[Atherosclerosis and infection?].
Atherosclerosis is guided by chronicle inflammation process. In the last decades of the 20th century, studies considering infection another possible risk factor of atherosclerosis development were written. Helicobacter pylori, Porphyromas gingivalis, some viruses but most frequently Chlamydia pneumonie are infection agens mentioned in these studies. Some of them emphasize also combined infections caused by more pathogenic factors having influence on vascular inflammation. Serological, epidemiological, histological and imunological studies show the pathogenic influence of acute or chronic infections. Many studies selected makrolid antibiotics as treatment in patients with ischaemic heart disease. However, existing experience with antibiotics did not bring clear results. These studies have mentioned the fact antibiotics have not been indicated as treatment in patients with acute or chronic vascular system infliction by atherosclerosis. Since the experimental and clinical research of influence of inflammations on the development of atherosclerosis moved forward a lot, no exact evidence of this complicated pathogenic mechanism was given. It will obviously take some time to confirm whether the relation between infections and artherosclerosis is causal, i.e. initiating the pathogenic process, accelerating it or keeping it alive.
Zeman
K
K
I. interní kardio-angiologická klinika Lékarské fakulty MU a FN u sv. Anny, Brno. kzeman@fnusa.cz
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000188:drug therapy / Q000276:immunology / Q000382:microbiology* / Q000473:pathology; D001424:Bacterial Infections / Q000150:complications* / Q000276:immunology; D023521:Chlamydophila Infections / Q000150:complications; D016993:Chlamydophila pneumoniae; D006801:Humans; D007109:Immunity; D007249:Inflammation; D012307:Risk Factors; D014777:Virus Diseases / Q000150:complications / Q000276:immunology
D000900:Anti-Bacterial Agents